妊娠脑与头颈肿瘤患者的笔束扫描质子治疗
本回顾性研究为7例接受X线放疗的妊娠患者(脑肿瘤4例、头颈肿瘤3例)制定笔束扫描质子治疗计划,用体模测量胎儿等效剂量。脑计划中质子治疗为0.4 mSv、X线放疗为7 mSv,头颈计划中分别为6 mSv和90 mSv。质子治疗在肿瘤覆盖与正常组织保护上均受医师青睐,胎儿等效剂量约降低至X线放疗的十分之一。
要点
- 脑肿瘤妊娠患者胎儿等效剂量:笔束扫描质子治疗0.4 mSv vs X线放疗7 mSv。
- 头颈肿瘤妊娠患者胎儿等效剂量:笔束扫描质子治疗6 mSv vs X线放疗90 mSv。
- 每日影像增加0.05至1.5 mSv总剂量,质子治疗计划在肿瘤覆盖和正常组织保护上均受医师青睐。
核心结论
- 治疗妊娠脑或头颈肿瘤患者时,笔束扫描质子治疗较X线放疗使胎儿等效剂量约降低至十分之一,且未在治疗计划目标上做出妥协。
- 结果支持将笔束扫描质子治疗作为妊娠脑或头颈肿瘤患者的新标准治疗实践,以替代X线放疗。
研究设计与样本
- 回顾性研究,为7例曾接受X线放疗的妊娠患者制定笔束扫描质子治疗计划,其中脑肿瘤4例、头颈肿瘤3例。
- 使用人体模体和置于腹部Wendi-2测量仪进行患者计划测量,以确定质子治疗与X线放疗的胎儿总等效剂量,并用Fluke 451剂量仪评估影像剂量。
主要发现
- 脑计划中计入光子和中子的平均实测胎儿等效剂量:笔束扫描质子治疗0.4 mSv vs X线放疗7 mSv。
- 头颈计划中平均实测胎儿等效剂量:笔束扫描质子治疗6 mSv vs X线放疗90 mSv。
- 医师对质子治疗计划在肿瘤覆盖和正常组织保护两方面均更为青睐。
- 每日影像使总剂量增加0.05至1.5 mSv。
临床怎么用
- 作者认为结果支持将笔束扫描质子治疗作为妊娠脑或头颈肿瘤患者的新标准治疗实践,以替代X线放疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: When radiation therapy is medically necessary for pregnant patients, photon-based treatments (XRT) have traditionally been used, whereas proton radiation therapy (PRT) is avoided due to concerns about neutron dose. This retrospective study analyzes pregnant patients treated with XRT and models the equivalent dose that would have been delivered to the fetus with proton radiation compared with XRT. The purpose of this work is to provide a comprehensive analysis of pencil beam scanning proton therapy (PBS-PRT) for pregnant patients and to evaluate whether PBS-PRT should be the new standard of practice for treating pregnant patients with brain and head and neck cancers. METHODS AND MATERIALS: PBS-PRT plans were made for seven pregnant patients who received XRT: four treated for brain tumors and three for head and neck tumors. Measurements were performed with the patient plans using an anthropomorphic phantom and Wendi-2 meter placed at the phantom's abdomen. Patient-specific measurements were used to determine the total fetal equivalent dose from PBS-PRT compared with XRT. Imaging dose was also evaluated with a Fluke 451 dose meter. RESULTS: The average measured fetal equivalent dose, accounting for photons and neutrons, for the brain plans was 0.4 mSv for PBS-PRT and 7 mSv for XRT. For the head and neck plans, it was 6 mSv and 90 mSv for PBS-PRT and XRT, respectively. The PBS-PRT plans were preferred by the physicians for both tumor coverage and normal-tissue sparing. Daily imaging added between 0.05 and 1.5 mSv to the total dose. CONCLUSIONS: This retrospective study showed that when treating brain or head and neck cancers in pregnant patients, fetal equivalent dose is reduced by approximately a factor of 10 with PBS-PRT compared with XRT without making any compromises in treatment planning objectives. These results support a change of practice to using PBS-PRT as the new standard for treating pregnant patients with brain or head and neck tumors compared with XRT.
引用
- Dupere JM, Lucido JJ, Breen WG, et al. Pencil Beam Scanning Proton Therapy for Pregnant Patients With Brain and Head and Neck Cancers. Int J Radiat Oncol Biol Phys. 2023. PMID: 37820769. doi:10.1016/j.ijrobp.2023.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。